Theravance biopharma, inc. (TBPH)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

332,798

58,064

102,403

178,311

223,235

378,021

101,202

103,854

125,831

88,980

91,301

139,626

169,945

344,709

86,572

148,363

128,803

112,707

127,114

97,090

100,899

89,215

122,228

268,199

-

0

Short-term marketable securities

154,233

222,767

217,278

217,761

210,823

127,255

199,207

249,049

292,700

259,586

243,700

222,194

222,823

156,387

143,910

101,316

51,073

59,727

68,856

113,896

135,337

165,396

162,489

80,997

-

0

Accounts receivable, net of allowances of $0 at December 31, 2019 and 2018, respectively

-

-

87

111

113

620

3,024

3,434

1,973

2,253

1,576

1,346

1,233

646

873

1,856

1,527

1,922

783

805

565

289

230

90

3

199

Receivables from collaborative arrangements

14,214

11,996

4,595

979

7,824

10,053

3,907

3,865

2,845

7,109

11,547

5,318

7,639

9,076

22,713

35,080

37,536

35,232

19,640

25,488

19,660

1,840

181

2

90

934

Receivables from licensing arrangements

1,200

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amounts due from TRC, LLC

26,282

28,574

16,661

20,019

-

5,422

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,243

-

-

Short-term restricted cash

-

-

7,496

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid taxes

-

-

-

-

310

-

314

944

926

291

289

242

3,083

3,060

3,168

3,150

242

12,764

-

-

-

0

-

-

-

-

Other prepaid and current assets

5,491

7,087

7,132

8,857

24,928

11,452

7,029

7,641

5,326

3,700

3,462

4,030

3,566

2,405

4,319

3,550

10,165

5,115

9,705

10,394

6,758

6,084

6,454

3,446

4,493

2,567

Inventories

-

-

-

-

-

-

17,923

17,906

17,217

16,830

15,258

12,126

13,215

12,220

12,480

9,810

9,406

10,005

12,141

12,553

12,337

12,546

15,129

14,756

11,014

10,406

Total current assets

534,218

338,488

355,652

426,038

467,233

532,823

332,606

386,693

446,818

378,749

367,133

384,882

421,504

528,503

274,035

303,125

238,752

237,472

238,239

260,226

275,556

275,370

306,711

382,733

15,600

14,106

Property and equipment, net

13,905

12,644

12,189

12,662

12,899

13,176

12,415

10,677

10,329

10,157

8,618

8,679

8,251

8,460

8,832

8,811

10,119

9,873

9,513

9,609

9,305

9,663

9,356

9,624

9,734

10,238

Long-term marketable securities

5,067

4,985

24,939

-

-

11,869

20,217

18,252

16,999

41,587

99,399

136,445

147,885

91,565

58,769

52,316

34,598

42,860

0

17,794

38,521

51,399

65,638

38,231

-

0

Operating lease assets

46,106

46,604

46,755

47,831

48,861

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

0

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

-

-

0

-

-

-

-

Tax receivable

3,972

3,682

3,664

3,695

-

-

3,131

3,143

3,324

8,191

8,070

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

833

0

0

833

833

Other assets

1,308

1,590

1,305

1,388

1,439

1,534

1,762

1,766

1,805

1,883

2,106

5,047

1,566

1,893

5,820

1,403

823

1,078

921

1,017

686

506

-

-

-

0

Total assets

605,409

408,826

445,337

492,447

531,265

560,235

370,964

421,364

480,108

441,400

486,159

543,886

588,039

639,254

356,289

374,488

293,125

300,116

257,506

289,479

324,901

337,771

381,705

430,588

26,167

25,177

Liabilities and Shareholders' Deficit
Current liabilities:
Accounts payable

6,645

4,758

8,713

3,501

5,596

9,028

3,745

3,644

5,085

5,924

5,623

6,406

3,626

1,733

5,351

7,412

9,092

18,804

5,963

6,335

4,021

9,921

5,284

9,499

4,984

6,940

Accrued personnel-related expenses

24,708

28,180

25,801

23,495

22,097

23,803

15,893

12,150

21,989

24,136

12,714

15,800

9,131

14,021

11,887

9,020

7,824

10,866

10,222

7,793

10,433

18,156

10,886

6,482

13,417

9,870

Accrued clinical and development expenses

22,658

17,587

10,907

7,404

9,207

11,876

14,100

14,508

16,435

20,657

20,487

26,386

28,036

25,064

23,859

22,650

23,640

14,709

6,652

6,674

6,628

7,871

-

-

-

-

Accrued interest payable

6,323

5,659

7,568

5,758

10,240

3,086

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-recourse notes due 2033, net

-

9,851

8,701

12,348

8,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

7,954

7,762

6,833

7,887

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

23,193

31,575

33,751

43,311

42,515

43,402

57,239

54,478

50,162

125

134

142

142

152

218

662

1,120

144

271

342

310

89

667

5,723

7,732

8,207

Other accrued liabilities

6,559

6,331

6,549

6,432

15,587

7,359

11,052

8,700

11,508

11,710

9,828

8,369

8,049

8,298

4,095

4,913

4,725

4,947

-

-

-

5,219

9,435

13,869

9,890

9,714

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,322

3,333

7,460

-

4,340

4,538

2,521

2,122

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,216

-

-

-

Total current liabilities

98,040

111,703

108,823

110,136

113,542

98,554

102,029

93,480

105,179

62,552

48,786

57,103

48,984

49,268

45,410

44,657

46,401

49,470

27,430

24,477

28,852

41,256

35,828

40,111

38,544

36,853

Convertible senior notes due 2023, net

226,158

225,890

225,622

225,354

225,086

224,818

224,550

224,282

224,014

223,746

223,478

223,210

222,942

222,676

-

-

-

0

-

-

-

-

-

-

-

-

Non-recourse notes due 2035, net

373,854

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-recourse notes due 2033, net

-

219,300

222,008

217,715

221,402

229,535

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

7,976

7,038

6,670

5,772

3,668

3,288

3,450

3,674

3,966

4,159

4,369

4,449

4,598

4,746

4,895

5,044

5,150

5,070

4,989

4,891

4,774

Long-term operating lease liabilities

47,199

47,725

48,620

48,565

48,493

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred revenue

8,511

6,761

14,169

13,444

21,733

26,179

22,469

34,220

45,651

1,436

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

9,583

21,287

8,900

14,457

14,261

24,762

28,323

28,325

36,085

34,820

26,490

18,996

18,493

13,113

8,847

3,878

3,738

2,983

2,785

2,433

1,890

1,578

986

-

-

585

Deferred revenue, non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

729

648

-

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Shareholders' Deficit
Preferred shares, $0.00001 par value: 230 shares authorized, no shares issued or outstanding

0

0

0

0

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Ordinary shares, $0.00001 par value: 200,000 shares authorized; 63,004 and 57,015 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

0

0

0

0

0

0

-

0

Additional paid-in capital

1,173,204

1,024,614

1,000,094

987,209

971,508

960,721

948,844

937,437

925,968

913,650

895,226

885,315

871,871

862,708

742,726

732,334

602,117

564,691

499,232

487,064

470,895

429,206

414,875

405,221

-

0

Accumulated other comprehensive income

512

145

94

129

-36

-166

-331

-525

-854

-733

-292

-248

-272

-253

39

181

126

-70

43

25

31

-82

-27

70

-

0

Accumulated deficit

-1,331,653

-1,248,600

-1,182,994

-1,124,563

-1,084,725

-1,012,145

-961,959

-902,526

-861,708

-797,740

-710,818

-643,941

-577,654

-512,225

-444,892

-410,931

-363,706

-321,556

-276,730

-229,415

-181,811

-139,337

-75,027

-20,532

-

0

Parent company deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-17,035

Total shareholders' deficit

-157,936

-223,840

-182,805

-137,224

-113,252

-51,589

-13,445

34,387

63,407

115,178

184,117

241,127

293,946

350,231

297,873

321,584

238,537

243,065

222,545

257,674

289,115

289,787

339,821

384,759

-17,916

-17,035

Total liabilities and shareholders' deficit

605,409

408,826

445,337

492,447

531,265

560,235

370,964

421,364

480,108

441,400

486,159

543,886

588,039

639,254

356,289

374,488

293,125

300,116

257,506

289,479

324,901

337,771

381,705

430,588

26,167

25,177